Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential

Autor: Søren P. Sheikh, Tilde Eskildsen, Sohrab Ayoubi
Rok vydání: 2016
Předmět:
0301 basic medicine
Myocytes
Cardiac/drug effects

Pathology
medicine.medical_specialty
Cell type
Vascular smooth muscle
Physiology
medicine.medical_treatment
Induced Pluripotent Stem Cells
Myocytes
Smooth Muscle

Regenerative medicine
Muscle
Smooth
Vascular

Cell therapy
03 medical and health sciences
Induced Pluripotent Stem Cells/cytology
Physiology (medical)
Cell Lineage/physiology
Journal Article
Vascular smooth muscle cells
Regeneration
Medicine
Animals
Humans
Cell Lineage
Myocytes
Cardiac

Induced pluripotent stem cell
Stem cell therapy
HiPSC
business.industry
Drug discovery
Myocytes
Smooth Muscle/metabolism

Regeneration (biology)
Cell Differentiation
Stem-cell therapy
030104 developmental biology
Muscle
Smooth
Vascular/cytology

Differentiation
Cardiology and Cardiovascular Medicine
business
Neuroscience
Zdroj: Ayoubi, S, Sheikh, S P & Eskildsen, T V 2017, ' Human induced pluripotent stem cell-derived vascular smooth muscle cells : differentiation and therapeutic potential ', Cardiovascular Research, vol. 113, no. 11, pp. 1282-1293 . https://doi.org/10.1093/cvr/cvx125
ISSN: 1755-3245
Popis: Cardiovascular diseases remain the leading cause of death worldwide and current treatment strategies have limited effect of disease progression. It would be desirable to have better models to study developmental and pathological processes and model vascular diseases in laboratory settings. To this end, human induced pluripotent stem cells (hiPSCs) have generated great enthusiasm, and have been a driving force for development of novel strategies in drug discovery and regenerative cell-therapy for the last decade. Hence, investigating the mechanisms underlying the differentiation of hiPSCs into specialized cell types such as cardiomyocytes, endothelial cells, and vascular smooth muscle cells (VSMCs) may lead to a better understanding of developmental cardiovascular processes and potentiate progress of safe autologous regenerative therapies in pathological conditions. In this review, we summarize the latest trends on differentiation protocols of hiPSC-derived VSMCs and their potential application in vascular research and regenerative therapy.
Databáze: OpenAIRE